Hangzhou Tigermed Consulting (03347) Releases Monthly Return for January 2026

Bulletin Express02-03

Hangzhou Tigermed Consulting Co., Ltd. (stock code: 03347) published its monthly return on movements in securities for the period ended 31 January 2026. The total authorised share capital remained at RMB 861,026,050, comprising 737,901,250 A shares and 123,124,800 H shares, each with a par value of RMB 1.

As of the end of January 2026, there were 732,017,470 issued A shares (excluding 5,883,780 held as treasury shares) and 123,124,800 issued H shares. No changes in the number of issued shares or treasury shares occurred during the reporting month. The public float requirement for H shares remained fulfilled.

All treasury shares were acquired between May 2024 and February 2025, with 3,922,520 of those treasury shares cancelled on 29 May 2025, leaving 5,883,780 shares held in treasury at 31 January 2026. No share options, warrants, convertibles, or other share-related arrangements were outstanding during the period, and no Hong Kong Depositary Receipts were issued.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1155318483?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-03 17:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155318483","market":"us","top_or_hot":-1,"title":"Hangzhou Tigermed Consulting (03347) Releases Monthly Return for January 2026","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (stock code: 03347) published its monthly return on movements in securities for the period ended 31 January 2026. The total authorised share capital remained at RMB 861,026,050, comprising 737,901,250 A shares and 123,124,800 H shares, each with a par value of RMB 1.</p>\n<p>As of the end of January 2026, there were 732,017,470 issued A shares (excluding 5,883,780 held as treasury shares) and 123,124,800 issued H shares. No changes in the number of issued shares or treasury shares occurred during the reporting month. The public float requirement for H shares remained fulfilled.</p>\n<p>All treasury shares were acquired between May 2024 and February 2025, with 3,922,520 of those treasury shares cancelled on 29 May 2025, leaving 5,883,780 shares held in treasury at 31 January 2026. No share options, warrants, convertibles, or other share-related arrangements were outstanding during the period, and no Hong Kong Depositary Receipts were issued.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hangzhou Tigermed Consulting (03347) Releases Monthly Return for January 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHangzhou Tigermed Consulting (03347) Releases Monthly Return for January 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-03 17:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (stock code: 03347) published its monthly return on movements in securities for the period ended 31 January 2026. The total authorised share capital remained at RMB 861,026,050, comprising 737,901,250 A shares and 123,124,800 H shares, each with a par value of RMB 1.</p>\n<p>As of the end of January 2026, there were 732,017,470 issued A shares (excluding 5,883,780 held as treasury shares) and 123,124,800 issued H shares. No changes in the number of issued shares or treasury shares occurred during the reporting month. The public float requirement for H shares remained fulfilled.</p>\n<p>All treasury shares were acquired between May 2024 and February 2025, with 3,922,520 of those treasury shares cancelled on 29 May 2025, leaving 5,883,780 shares held in treasury at 31 January 2026. No share options, warrants, convertibles, or other share-related arrangements were outstanding during the period, and no Hong Kong Depositary Receipts were issued.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1155318483","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155318483","pubTimestamp":1770109880,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (stock code: 03347) published its monthly return on movements in securities for the period ended 31 January 2026. The total authorised share capital remained at...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"杭州泰格医药咨询(03347)发布2026年1月月报表","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (stock code: 03347) published its monthly return on movements in securities for the period ended 31 January 2026. The total authorised share capital remained at RMB 861,026,050, comprising 737,901,250 A shares and 123,124,800 H shares, each with a par value of RMB 1.\nAs of the end of January 2026, there were 732,017,470 issued A shares (excluding 5,883,780 held as treasury shares) and 123,124,800 issued H shares. No changes in the number of issued shares or treasury shares occurred during the reporting month. The public float requirement for H shares remained fulfilled.\nAll treasury shares were acquired between May 2024 and February 2025, with 3,922,520 of those treasury shares cancelled on 29 May 2025, leaving 5,883,780 shares held in treasury at 31 January 2026. No share options, warrants, convertibles, or other share-related arrangements were outstanding during the period, and no Hong Kong Depositary Receipts were issued.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1155318483","isCrawlerRequest":true}